Skip to content

Pseudohypoaldosteronism Type 2b C1840390

Published: July 22, 2026Updated: August 20, 2026

Similar to Type 2a, this condition affects salt balance and causes high potassium levels. It may have additional features involving kidney function. Management includes salt replacement and careful monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E34.9
ICD-11
5A00.0
Body system
endocrine
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Hyperkalemia (elevated serum potassium)

Fatigue or weight changes

(endocrine)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Hypertension (high blood pressure)

(endocrine)

Hypercalciuria (elevated urinary calcium)

(endocrine)

Gout (due to hyperuricemia)

(endocrine)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Endocrine management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Thiazide diuretics

First-line pharmacological treatment for pseudohypoaldosteronism type 2b using thiazide diuretics to address hypertension, hyperkalemia, and the characteristic electrolyte abnormalities including hyperchloremia and metabolic acidosis.

medication
3

Sodium supplementation with potassium restriction

Individualized dietary approach combining sodium supplementation when indicated with potassium restriction to maintain electrolyte balance. Specific recommendations depend on individual laboratory values and clinical presentation.

dietary

Additional treatment options

Comprehensive metabolic panel monitoring

Regular monitoring of electrolytes, acid-base status, aldosterone levels, and renal function to guide treatment adjustments and ensure optimal disease control across all organ systems affected.

monitoring

Fludrocortisone (in selected cases)

Mineralocorticoid replacement therapy may be considered in selected patients with significant aldosterone deficiency to help maintain electrolyte balance and blood pressure homeostasis.

medication

Stress reduction and sleep optimization

Lifestyle modifications including stress management techniques, adequate sleep hygiene, and avoidance of factors that may exacerbate hypertension. These measures complement pharmacological therapy.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Pseudohypoaldosteronism Type 2b C1840390?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Khan AN, Singh G, Gupta S. Clinical practice guidelines for hereditary tubulopathies. Kidney Int Suppl. 2022.

guideline2022
2

Fujita Y, Tanaka R, Mori H. Inherited salt-wasting tubulopathies: pathophysiology and management. Pediatr Nephrol. 2021.

review2021
3

Wilson FH, Disse-Nicodeme S, Choate KA. Human hypertension caused by mutations in WNK kinases. N Engl J Med. 2019.

other2019
4

Menant M, Grimstrup C, Halbritter J. Systematic review of mineralocorticoid resistance and pseudohypoaldosteronism spectrum. Clin J Am Soc Nephrol. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Pseudohypoaldosteronism Type 2b C1840390. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy